February
FDA awards grant for cancer drug study
The US FDA has awarded a $1.6m grant under its orphan drugs programme to a Alabama-based biotech company Egen to help the company with clinical trials of a potential new therapy for ovarian cancer
03 Feb 2011
Lilly and BMS halt cancer study enrolment
Lilly and BMS have halted enrolment in a late-stage clinical study of an investigational treatment for advanced non-small cell lung cancer due to safety concerns
03 Feb 2011
Nestlé acquires CM&D Pharma
Nestlé Health Science has acquired CM&D Pharma, a small UK company specialising in kidney disease, inflammatory bowel disease and colon cancer
03 Feb 2011
Report reveals record patent expiries
A report from EvaluatePharma shows that 13 US blockbuster drugs will lose patent exclusivity in the next two years
03 Feb 2011
Merck/MSD posts $531m loss for Q4 2010
Merck/MSD has announced a $531m loss in the final quarter of 2010, however the company posted worldwide sales of £46bn for the year
03 Feb 2011
Valeant acquires GSK's Zovirax
Valeant Pharmaceuticals' Biovail Laboratories has signed a deal under which it will acquire all US and Canadian rights to certain formulations of GSK's Zovirax
04 Feb 2011
Lilly partners with diabetes group
Lilly has formed a partnership with the Juvenile Diabetes Research Foundation aimed at using regenerative medicine to treat type 1 diabetes
04 Feb 2011
Bayer GIST drug wins US orphan status
Bayer has been granted orphan status by the US Food and Drug Administration for an investigational treatment for gastrointestinal stromal tumours
07 Feb 2011
K-V preterm birth drug approved
K-V Pharmaceutical's Makena has received US approval as the first drug indicated to reduce the risk of preterm birth in women pregnant with one child who have a history of spontaneous preterm birth
07 Feb 2011
PhRMA appoints new EVP of public affairs
The Pharmaceutical Research and Manufacturers of America has appointed Josephine Martin as executive vice president, public affairs
07 Feb 2011